High-risk retinoblastoma based on age at primary enucleation: a study of 616 eyes

Swathi Kaliki1, Shweta Gupta2, George Ramappa2

  • 1The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, 500034, India. kalikiswathi@yahoo.com.

Eye (London, England)
|November 27, 2019
PubMed

Insights

High-risk retinoblastoma features differ by age at enucleation. Younger children (<1 year) showed more bilateral disease and buphthalmos, while older children (>4 years) had more anterior chamber pseudohypopyon and vitreous seeds.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Pathology

Background:

  • Retinoblastoma is the most common primary intraocular malignancy in children.
  • Histopathological features are crucial for risk stratification and treatment planning.
  • Age at diagnosis and enucleation can influence disease presentation and outcomes.

Purpose of the Study:

  • To investigate the association between age at primary enucleation and high-risk histopathological features of retinoblastoma.
  • To identify age-specific patterns in retinoblastoma presentation and pathology.

Main Methods:

  • Retrospective analysis of 616 patients with retinoblastoma.
  • Data collected included age at enucleation, clinical presentation, and histopathological findings.
  • Statistical analysis to determine significant differences in features across age groups.

Main Results:

  • Significant differences in clinical and histopathological features were observed based on age at enucleation.
  • Children ≤1 year were more likely to present with bilateral retinoblastoma and buphthalmos.
  • Older children (>4 years) showed a higher prevalence of anterior chamber pseudohypopyon and vitreous seeds.
  • High-risk features, including optic nerve and choroidal infiltration, varied significantly with age.

Conclusions:

  • The predominant high-risk histopathological features of retinoblastoma are age-dependent.
  • Understanding these age-related variations is essential for tailored risk assessment and management strategies in retinoblastoma.
Abstract